Author Correction: XBP-1 and the unfolded protein response (UPR) (Nature Immunology, (2020), 21, 9, (963-965), 10.1038/s41590-020-0708-3)

Laurie H. Glimcher; Ann Hwee Lee; Neal N. Iwakoshi

doi:10.1038/s41590-020-00837-6

Author Correction: XBP-1 and the unfolded protein response (UPR) (Nature Immunology, (2020), 21, 9, (963-965), 10.1038/s41590-020-0708-3)

Laurie H. Glimcher, Ann Hwee Lee, Neal N. Iwakoshi

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the version of this article initially published, the Competing Interests declaration was incorrect. The correct declaration is “L.H.G. is a former director of Bristol-Myers Squibb and the Waters Corporation and is currently on the board of directors of GlaxoSmithKline Pharmaceuticals and Analog Devices, Inc. She also serves on the scientific advisory boards of Repare Therapeutics, Abpro Therapeutics and Kaleido Therapeutics. A.-H.L. is an employee of Regeneron Pharmaceuticals and holds stock options in the company.” The error has been corrected in the HTML and PDF versions of the article.

Original language	English (US)
Pages (from-to)	100
Number of pages	1
Journal	Nature immunology
Volume	22
Issue number	1
DOIs	https://doi.org/10.1038/s41590-020-00837-6
State	Published - Jan 2021
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2020, The Author(s), under exclusive licence to Springer Nature America, Inc.

PubMed: MeSH publication types

Published Erratum

Publisher link

10.1038/s41590-020-00837-6

Find It

Find It at U of M Libraries

Cite this

@article{c0aad8d5f63f48519d9ee8efa8c6bc76,

title = "Author Correction: XBP-1 and the unfolded protein response (UPR) (Nature Immunology, (2020), 21, 9, (963-965), 10.1038/s41590-020-0708-3)",

abstract = "In the version of this article initially published, the Competing Interests declaration was incorrect. The correct declaration is “L.H.G. is a former director of Bristol-Myers Squibb and the Waters Corporation and is currently on the board of directors of GlaxoSmithKline Pharmaceuticals and Analog Devices, Inc. She also serves on the scientific advisory boards of Repare Therapeutics, Abpro Therapeutics and Kaleido Therapeutics. A.-H.L. is an employee of Regeneron Pharmaceuticals and holds stock options in the company.” The error has been corrected in the HTML and PDF versions of the article.",

author = "Glimcher, {Laurie H.} and Lee, {Ann Hwee} and Iwakoshi, {Neal N.}",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s), under exclusive licence to Springer Nature America, Inc.",

year = "2021",

month = jan,

doi = "10.1038/s41590-020-00837-6",

language = "English (US)",

volume = "22",

pages = "100",

journal = "Nature immunology",

issn = "1529-2908",

publisher = "Nature Research",

number = "1",

}

TY - JOUR

T1 - Author Correction

T2 - XBP-1 and the unfolded protein response (UPR) (Nature Immunology, (2020), 21, 9, (963-965), 10.1038/s41590-020-0708-3)

AU - Glimcher, Laurie H.

AU - Lee, Ann Hwee

AU - Iwakoshi, Neal N.

PY - 2021/1

Y1 - 2021/1

N2 - In the version of this article initially published, the Competing Interests declaration was incorrect. The correct declaration is “L.H.G. is a former director of Bristol-Myers Squibb and the Waters Corporation and is currently on the board of directors of GlaxoSmithKline Pharmaceuticals and Analog Devices, Inc. She also serves on the scientific advisory boards of Repare Therapeutics, Abpro Therapeutics and Kaleido Therapeutics. A.-H.L. is an employee of Regeneron Pharmaceuticals and holds stock options in the company.” The error has been corrected in the HTML and PDF versions of the article.

AB - In the version of this article initially published, the Competing Interests declaration was incorrect. The correct declaration is “L.H.G. is a former director of Bristol-Myers Squibb and the Waters Corporation and is currently on the board of directors of GlaxoSmithKline Pharmaceuticals and Analog Devices, Inc. She also serves on the scientific advisory boards of Repare Therapeutics, Abpro Therapeutics and Kaleido Therapeutics. A.-H.L. is an employee of Regeneron Pharmaceuticals and holds stock options in the company.” The error has been corrected in the HTML and PDF versions of the article.

UR - http://www.scopus.com/inward/record.url?scp=85095869893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85095869893&partnerID=8YFLogxK

U2 - 10.1038/s41590-020-00837-6

DO - 10.1038/s41590-020-00837-6

M3 - Comment/debate

C2 - 33184511

AN - SCOPUS:85095869893

SN - 1529-2908

VL - 22

SP - 100

JO - Nature immunology

JF - Nature immunology

IS - 1

ER -

Author Correction: XBP-1 and the unfolded protein response (UPR) (Nature Immunology, (2020), 21, 9, (963-965), 10.1038/s41590-020-0708-3)

Abstract

Bibliographical note

PubMed: MeSH publication types

Publisher link

Find It

Other files and links

Fingerprint

Cite this